ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $795,276 | -50.5% | 265,092 | -38.3% | 0.00% | – |
| Q2 2023 | $1,606,314 | +0.5% | 429,496 | -10.0% | 0.00% | – |
| Q1 2023 | $1,598,571 | -24.3% | 477,185 | +8.6% | 0.00% | – |
| Q4 2022 | $2,112,715 | -25.2% | 439,234 | -11.6% | 0.00% | – |
| Q3 2022 | $2,826,000 | +1.4% | 496,980 | +26.6% | 0.00% | – |
| Q2 2022 | $2,787,000 | -10.0% | 392,516 | -8.4% | 0.00% | – |
| Q1 2022 | $3,095,000 | -46.1% | 428,621 | -33.3% | 0.00% | -100.0% |
| Q4 2021 | $5,746,000 | -63.0% | 642,742 | +45.2% | 0.00% | -50.0% |
| Q3 2021 | $15,520,000 | -8.5% | 442,686 | -43.9% | 0.00% | 0.0% |
| Q2 2021 | $16,954,000 | +370.8% | 789,348 | +1253.5% | 0.00% | +100.0% |
| Q1 2021 | $3,601,000 | -19.1% | 58,321 | -45.3% | 0.00% | 0.0% |
| Q4 2020 | $4,453,000 | – | 106,587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $4,712,400 | 33.11% |
| BML Capital Management, LLC | 2,236,239 | $8,363,534 | 7.52% |
| TANG CAPITAL MANAGEMENT LLC | 3,026,455 | $11,318,942 | 1.67% |
| Stonepine Capital Management, LLC | 752,088 | $2,812,809 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $9,296,286 | 0.96% |
| CM Management, LLC | 250,000 | $935 | 0.91% |
| EcoR1 Capital, LLC | 6,995,861 | $26,164,520 | 0.64% |
| Cormorant Asset Management, LP | 1,547,181 | $5,786,457 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 501,537 | $1,875,748 | 0.31% |
| Auour Investments LLC | 177,000 | $661,980 | 0.28% |